Visceral leishmaniasis/human immunodeficiency virus co-infection in India: The focus of two epidemics

Journal of Medical Microbiology

Volumn 55, Issue 7, 2006, Pages 919-922

  Mathur, Purva ^a   Samantaray, J C ^a   Vajpayee, Madhu ^a   Samanta, Palash ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CHILD; COMORBIDITY; CONTROLLED STUDY; EPIDEMIC; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LEISHMANIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKIN LEISHMANIASIS; TERTIARY HEALTH CARE; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; AGED; ANIMALS; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HIV; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; INDIA; INFANT; LEISHMANIA; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 33745662611     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46574-0     Document Type: Article

References (11)

1. Alvar, J., Canavate, C, Gutierresz-Solar, B. Jimenez M., Laguna, F., Lopez-Velez, R., Molina, R. & Moreno, J. (1997). Leishmania and Human Immunodeficiency Virus coinfection: the first 10 years. Clin Microbiol Rev 10, 298-319.
2. Bora, D. (1999). Epidemiology of visceral leishmaniasis in India. Natl Med J India 12, 62-68.
3. Centres for Disease Control and Prevention (2001). Revised guidelines for HIV counseling, testing and referral. Morb Mortal Wkly Rep 50, RRI9, 1-58.
4. Lopez-Velez, R., Jose, A., Molina, P., Guerrero, A., Baquero, F. & Villarrubia, J. (1998). Clinicoepidemiologic characteristics, prognostic factors and survival analysis of patients coinfected with Human Immunodeficiency Virus and Leishmania in an area of Madrid, Spain. Am J Trap Med Hyg 58, 436-443.
5. Pintado, V. & Lopez-Velez, R. (2001). HIV-associated visceral leishmaniasis. Clin Microbiol Infect 7, 291-300.
6. Pintado, V., Martin-Rabadan, P., Rivera, M., Moreno, S., Bouza, E. (2001). Visceral leishmaniasis in Human Immunodeficiency Virus (HIV)-infected and non HIV infected patients. Medicine 80, 54-73.
7. Sinha, P. K., Rabidas, V. N., Pandey, K., Verma, N., Gupta, A. K., Ranjan, A. & Das, B. (2003). Visceral leishmaniasis and HIV coinfection in Bihar, India. J Acq Immun Def Syndr 32, 115-116.
8. Thakur, C. P., Sinha, P. K., Singh, R. K., Hassan, S. M. & Narain, S. (2000). Miltefosine in a case of visceral leishmaniasis with HIV co-infection and rising incidence of this disease in India. Trop Med Hyg 94, 696-697.
9. Thakur, C. P., Narayan, S. & Ranjan, A. (2003). Kala-azar (visceral leishmaniasis) and HIV coinfection in Bihar, India: is this combination increasing? J Acq Immun Def Syndr 32, 512-513.
10. USAID (2003). HIV/AIDS country profile, India, March, http://www.usaid.gov/our_work/global_health/aids/countries/ane/India_05.pdf
11. World Health Organization (1995). Report on the Consultative Meeting on Leishmania/HIV Co-infection. Report no. WHO/LEISH/95.35, pp. 1-14. Geneva: World Health Organization.